<?xml version="1.0" encoding="UTF-8"?>
<p>The incubation period of the disease is 5-6 d on average but can be up to 14 d. Critical epidemiological and immunological aspects of the disease are that an infected person may be contagious 1-3 d before the onset of the symptoms[
 <xref rid="B47" ref-type="bibr">47</xref>]. About 40% of COVID-19 patients experience mild clinical course, and another 40% present with moderate disease. Severe disease that requires oxygen support is observed in about 15% of the patients. Five percent of the infected ones develop a severe disease that progresses to respiratory failure (ARDS) but also sepsis and septic shock, thromboembolism, multiorgan failure, including acute kidney, and cardiac injury[
 <xref rid="B48" ref-type="bibr">48</xref>]. Advanced age, smoking, as well as comorbidities such as diabetes, hypertension, cardiac and chronic lung disease, cerebrovascular diseases, immunosuppression, and cancer have been reported to predispose to a severe course of COVID-19. Children and infants usually experience mild disease or asymptomatic infection[
 <xref rid="B49" ref-type="bibr">49</xref>].
</p>
